We are live on
!
Find out more
EPM
Equitec Proprietary Markets Portfolio holdings
AUM
$187M
1-Year Est. Return
179.87%
This Fund
S&P 500
This Quarter
Est. Return
+23.9%
1 Year Est. Return
+179.87%
3 Year Est. Return
+470.49%
5 Year Est. Return
+544.99%
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$34.7M
(-25%)
Cap. Flow
-$44.6M
Cap. Flow
% of AUM
-42.09%
Top 10 Holdings %
Top 10 Hldgs %
87.06%
Holding
85
New
19
Increased
12
Reduced
9
Closed
20
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$9.61M |
| 2 |
K
Kellanova
K
|
+$4.37M |
| 3 |
KBDC
Kayne Anderson BDC
KBDC
|
+$642K |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$470K |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$233K |
Top Sells
| 1 |
X
US Steel
X
|
+$10.1M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.57M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$7.27M |
| 4 |
AMED
Amedisys
AMED
|
+$1.61M |
| 5 |
BLUE
bluebird bio
BLUE
|
+$540K |
Sector Composition
| 1 | Healthcare | 12.37% |
| 2 | Consumer Staples | 6.77% |
| 3 | Financials | 1.97% |
| 4 | Industrials | 1.08% |
| 5 | Utilities | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1
PUT
DELISTED
Blueprint Medicines
BPMC
| $17.5M | 16.52% |
+136,500
| New | +$14.2M |
|
|
PARA
2
PUT
DELISTED
Paramount Global Class B
PARA
| $13.7M | 12.96% |
1,064,100
-199,500
| -16% | -$2.34M |
|
|
K
3
PUT
DELISTED
Kellanova
K
| $13.6M | 12.82% |
170,700
+113,000
| +196% | +$9.23M |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $11.9M | 11.2% |
+92,500
| New | +$9.61M |
|
|
K
5
CALL
DELISTED
Kellanova
K
| $11.7M | 11.07% |
147,400
+31,800
| +28% | +$2.6M |
|
|
FL
6
CALL
DELISTED
Foot Locker
FL
| $7.97M | 7.52% |
+325,200
| New | +$5.91M |
|
|
K
7
DELISTED
Kellanova
K
| $6.88M | 6.5% |
86,560
+53,500
| +162% | +$4.37M |
|
|
PARA
8
CALL
DELISTED
Paramount Global Class B
PARA
| $5.39M | 5.09% |
417,900
-440,500
| -51% | -$5.16M |
|
|
KBDC
9
Kayne Anderson BDC
KBDC
$910M
| $1.86M | 1.76% |
121,998
+40,666
| +50% | +$642K |
|
|
WBA
10
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $1.72M | 1.62% |
149,600
+99,500
| +199% | +$1.11M |
|
|
AMED
11
PUT
DELISTED
Amedisys
AMED
| $1.29M | 1.22% |
13,100
-10,100
| -44% | -$956K |
|
|
WBA
12
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $1.05M | 0.99% |
91,300
+8,800
| +11% | +$98K |
|
|
SAGE
13
PUT
DELISTED
Sage Therapeutics
SAGE
| $1.04M | 0.98% |
+113,500
| New | +$835K |
|
|
VERV
14
PUT
DELISTED
Verve Therapeutics
VERV
| $955K | 0.9% |
+85,000
| New | +$485K |
|
15
CALL
SiriusXM
SIRI
$10.3B
| $903K | 0.85% |
39,300
+27,300
| +228% | +$588K |
|
|
SPR
16
DELISTED
Spirit AeroSystems
SPR
| $828K | 0.78% |
21,700
+4,000
| +23% | +$144K |
|
|
SPR
17
PUT
DELISTED
Spirit AeroSystems
SPR
| $763K | 0.72% |
20,000
+5,000
| +33% | +$180K |
|
18
CALL
Herc Holdings
HRI
$4.99B
| $658K | 0.62% |
+5,000
| New | +$607K |
|
|
19
PUT
Herc Holdings
HRI
$4.99B
| $658K | 0.62% |
+5,000
| New | +$607K |
|
|
JNPR
20
CALL
DELISTED
Juniper Networks
JNPR
| $599K | 0.57% |
15,000
| – | – |
|
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $583K | 0.55% |
+63,900
| New | +$470K |
|
|
WBA
22
DELISTED
Walgreens Boots Alliance
WBA
| $512K | 0.48% |
44,600
+8,600
| +24% | +$95.7K |
|
|
JNPR
23
PUT
DELISTED
Juniper Networks
JNPR
| $399K | 0.38% |
+10,000
| New | +$358K |
|
24
Cadiz
CDZI
$286M
| $323K | 0.31% |
108,046
| – | – |
|
|
VERV
25
CALL
DELISTED
Verve Therapeutics
VERV
| $320K | 0.3% |
+28,500
| New | +$162K |
|
Similar funds
PP
WWA
CQWA
CI
TH
BAH
BWG
AWS
Equitec Proprietary Markets's Q2 2025 Portfolio in Review
As of Q2 2025, Equitec Proprietary Markets held 85 positions worth $106M, down 25% from $141M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Equitec Proprietary Markets withdrew a net $44.6M in Q2 2025, closing 20 positions and reducing 9 holdings. Its most notable exit was US Steel, an estimated $10.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 7% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Equitec Proprietary Markets opened a new position in Blueprint Medicines worth $11.9M.
- Equitec Proprietary Markets's largest Q2 2025 buy was Blueprint Medicines: 92,500 shares worth $11.9M.
- Equitec Proprietary Markets added most to Kellanova in Q2 2025, an estimated $4.37M increase.
- Equitec Proprietary Markets's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $8.57M.
- Equitec Proprietary Markets fully exited US Steel in Q2 2025, selling an estimated $10.1M.
- Equitec Proprietary Markets's ten largest holdings make up 87% of its $106M portfolio in Q2 2025.
- Equitec Proprietary Markets opened 19 new positions and closed 20 in Q2 2025.
- Equitec Proprietary Markets's portfolio value fell 25% quarter-over-quarter to $106M.
Based on Equitec Proprietary Markets's 13F filing for Q2 2025, filed 6 Aug 2025.